Long-acting injectable drug prevents HIV among men and transgender women
On May 18, 2020, an investigational long-acting form of the HIV drug cabotegravir injected once every 8 weeks…
Electron microscopy technique revealed how a key human antibody disarms many strains of HIV
On Apr. 29, 2020, Scripps researchers announced they had developed a method for examining the machinery of HIV…
Potential new HIV treatment developed at University of Nebraska Medical Center
On Apr. 27, 2020, a novel means to prevent HIV infection was developed at the University of Nebraska…
First patients enrolled in new Oxford University clinical trial of possible COVID-19 treatments
On Mar. 23, 2020, researchers from the University of Oxford the launch of a new clinical trial to…
Newer anti-HIV drugs safest, most effective during pregnancy
On Mar. 11, 2020, the antiretroviral drugs dolutegravir and emtricitabine/tenofovir alafenamide fumarate (DTG+FTC/TAF) may comprise the safest and…
ImmunityBio announced durable virus control of SHIV without anti-retroviral therapy
On Mar. 10, 2020, ImmunityBio announced results from studies evaluating N-803, an IL-15 superagonist, alone and in combination…
Biotechnology | HIV | NIH
Drug-delivery technology leads to sustained HIV antibody production in NIH study
On Mar. 9, 2020, researchers from the National Institute of Allergy and Infectious Diseases (NIAID), part of the…
NIHs Study found lower concentration of PrEP drug in young women during pregnancy than postpartum
On Mar. 9, 2020, among African adolescent girls and young women who took HIV pre-exposure prophylaxis (PrEP) daily,…
Fred Hutch trial halted after promising HIV vaccine failed to show efficacy
On Feb. 4, 2020, the Fred Hutchinson Cancer Research Center announced that a promising HIV vaccine trial was…
Xencor and Gilead entered license agreement for use of XmAb antibody technologies in investigational agents for HIV
On Jan. 8, 2020, Xencor announced a technology license agreement in which Gilead Sciences will access Xencor’s Xtend…
PATH announced Nikolaj Gilbert as President and CEO
On Dec. 4, 2019, PATH announced that its Board of Directors had unanimously chosen global development leader Nikolaj…
Abbott announced discovery of a new strain of HIV
On Nov. 6, 2019, Abbott announced that a team of its scientists identified a new subtype of the…
Chembio Diagnostics received WHO prequalification approval for HIV Self-Test
On Nov. 4, 2019, Chembio Diagnostics announced its SURE CHECK HIV Self-Test has received World Health Organization (WHO)…
Biotechnology | CDC | Disease | HIV | Non-Profit Research | Pharmaceutical | Vaccine
CDC published ACIP recommendations for use of meningococcal conjugate vaccines in HIV-infected persons
On Nov. 4, 2016, the U.S. Centers for Disease Control and Prevention’s (CDC) Immunization Practices Advisory Committee (ACIP)…
HIV research cleared name of ‘Patient Zero,’ Gaetan Dugas
On Oct, 26, 2016, a team of researchers at the University of Arizona and University of Cambridge in…
UNMC researchers probed aging, HIV-infected brain with $22 million NIH grant
On Apr. 4, 2016, UNMC researchers, Tony Wilson, Ph.D., and Susan Swindells, M.B.B.S., working with a $2.2 million,…
The New England Primate Research Center closed its doors
On May 31, 2015, the New England Primate Research Center (NEPRC) closed its doors. During its five decades…
OHSU scientist awarded $25 million grant to further HIV vaccine research
On Sept. 3, 2014, Oregon Health & Science University (OHSU) announced it had been awarded a $25 million…
Myron Cohen received the North Carolina Award for Science
On Oct. 22, 2013 Myron Cohen received the North Carolina Award for Science. Dr. Cohen is a University…
HIV/AIDS researcher David Ho won NIDA’s 2011 Avant-Garde Award
On Aug. 12, 2011, the National Institute on Drug Abuse (NIDA), part of NIH, announced that Dr. David…
Biotechnology | CDC | Disease | HIV | Infectious Disease
The CDC marked the first AIDS cases reported
On Jun. 11, 2011, the U.S. Centers for Disease Control and Prevention (CDC) marked the 30th year since…
The first preventative vaccine for HIV was developed at University of Western Ontario
On Dec. 20, 2011, the U.S. Food and Drug Administration (FDA) announced approval of the first and only…
National Women and Girls HIV/AIDS Awareness Day was established
On Mar. 10, 2010, National Women and Girls HIV/AIDS Awareness Day (NWGHAAD) was established as a nationwide initiative…
Thai HIV vaccine clinical trial results were published in the New England Journal of Medicine
On Dec. 3, 2009, the Thai HIV vaccine clinical trial results were published in the New England Journal…
Biotechnology | HIV | Therapeutics | Vaccine
Phase III results for first HIV/AIDS (Aidsvax) vaccine reported
On Sept. 24, 2009, the second Phase III HIV-1 vaccine trial, also known as RV144, that began in…
Francoise Barre-Sinoussi was awarded a share of the Nobel Prize in Physiology or Medicine for the discovery of the human immunodeficiency virus
On Oct. 6, 2008, Francoise Barre-Sinoussi was awarded a share of the 2008 Nobel Prize in Physiology or…
The first HIV case in history was recognized
Jun. 25, 2008, researchers reported that the human immunodeficiency virus (HIV-1) responsible for most of the AIDS cases…
National Cancer Institute symposium showcased HIV/AIDS research
On Oct. 2, 2007, the National Cancer Institute held a symposium to showcase several important historic achievements in…
UCLA launched $20 million stem cell institute to investigate new approaches to HIV, cancer and neurological disorders
On Mar. 16, 2005, University of California, Los Angeles (UCLA) officials announced the formation of the Institute for…
OHSU VGTI received a $3.5 million NIH grant to assist in development of AIDS vaccine
On May 25, 2004, researchers at the Vaccine and Gene Therapy Institute (VGTI) and the Oregon National Primate…